Literature DB >> 24790252

Patenting genes: what does Association for Molecular Pathology v. Myriad Genetics mean for genetic testing and research?

Lara Cartwright-Smith1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24790252      PMCID： PMC3982540          DOI： 10.1177/003335491412900311

Source DB:  PubMed          Journal:  Public Health Rep        ISSN： 0033-3549            Impact factor:   2.792


× No keyword cloud information.
  3 in total

1.  Effects of patents and licenses on the provision of clinical genetic testing services.

Authors:  Mildred K Cho; Samantha Illangasekare; Meredith A Weaver; Debra G B Leonard; Jon F Merz
Journal:  J Mol Diagn       Date:  2003-02       Impact factor: 5.568

2.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

3.  Pervasive sequence patents cover the entire human genome.

Authors:  Jeffrey A Rosenfeld; Christopher E Mason
Journal:  Genome Med       Date:  2013-03-25       Impact factor: 11.117
  3 in total
  3 in total

Review 1.  BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment Paradigms.

Authors:  Naomie Devico Marciano; Gianna Kroening; Farshid Dayyani; Jason A Zell; Fa-Chyi Lee; May Cho; Jennifer Goldstein Valerin
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

2.  Corporate control and global governance of marine genetic resources.

Authors:  Robert Blasiak; Jean-Baptiste Jouffray; Colette C C Wabnitz; Emma Sundström; Henrik Österblom
Journal:  Sci Adv       Date:  2018-06-06       Impact factor: 14.136

3.  A novel method to detect the Mexican founder mutation BRCA1 ex9‑12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan® probes.

Authors:  Denisse Aideé Martínez-Treviño; Rafael Baltazar Reyes León-Cachón; Cynthia Villarreal-Garza; Dione Aguilar Y Méndez; Elisa Aguilar-Martínez; Hugo Alberto Barrera-Saldaña
Journal:  Mol Med Rep       Date:  2018-06-06       Impact factor: 2.952
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.